Skip to content
Syntara
A clinical‐stage drug development company primarily focused on blood related cancers.
SyntaraSyntara
  • Welcome
  • People
    • Board
    • Management
  • Pipeline
    • Cancer
    • Skin Scarring
    • Neuroinflammation
  • Clinical Trials
  • Investors
    • Investors home page
    • ASX Announcements
    • Quarterly Reports
    • Annual & Half-Yearly Reports
    • Investor Presentations
    • Media
    • Analyst Reports
    • Shareholders
    • Shareholder Services
    • Corporate Governance
  • Contact
  • Welcome
  • People
    • Board
    • Management
  • Pipeline
    • Cancer
    • Skin Scarring
    • Neuroinflammation
  • Clinical Trials
  • Investors
    • Investors home page
    • ASX Announcements
    • Quarterly Reports
    • Annual & Half-Yearly Reports
    • Investor Presentations
    • Media
    • Analyst Reports
    • Shareholders
    • Shareholder Services
    • Corporate Governance
  • Contact

Monthly Archives: May 2023

You are here:
  1. Home
  2. 2023
  3. May

Syntara is a clinical stage drug development company focused on haematological malignancies.

Linkedin

ABN 75 082 811 630

Quick Links
  • Pipeline
  • Investors
  • Highlights
  • Pipeline
  • Investors
  • Highlights
Subscribe to our News
Get In Touch
  • Locked Bag 5015 
    Frenchs Forest 
NSW 2086
    AUSTRALIA
  • info@syntaratx.com.au 
  • +61 2 8760 1480

2025 © Syntara Limited.

Legal

Go to Top